NCT06912035View on ClinicalTrials.gov

Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

November 8, 2024

Study Completion Date

November 8, 2024

Conditions

Uncontrolled DiabetesDiabetes Mellitus Type 2

Interventions

DRUG

Diacerein 50 mg Capsule

The patients received diacerein capsules

DRUG

Placebo

Patients received placebo capsules

Trial Locations (1)

30126

Universitas Sriwijaya, Palembang

All Listed Sponsors

collaborator

Indonesia Endowment Fund for Education (LPDP), Ministry of Finance Republik of Indonesia

UNKNOWN

lead

Universitas Sriwijaya

OTHER

NCT06912035 - Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang | Biotech Hunter | Biotech Hunter